Body

WHAT:

(WASHINGTON - October 30, 2009) – Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.

Paleontologists from the University of California, Berkeley, and the Museum of the Rockies have wiped out two species of dome-headed dinosaur, one of them named three years ago – with great fanfare – after Hogwarts, the school attended by Harry Potter.

With the rapidly increasing problem of cardiovascular (CVD) disease in Asia Pacific (AP), there is an urgency to raise awareness of risk factors. The European Society of Cardiology (ESC) is addressing the need to develop and adopt an integrated approach to CVD management, through important events organised in the region.

Pasadena, Calif.—Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

"Gene therapy in these models successfully attenuated the symptoms of Huntington's disease and increased life span," notes Paul Patterson, the Anne P. and Benjamin F. Biaggini Professor of Biological Sciences.

PHILADELPHIA, P.A., October 30, 2009 – MedImmune announced today it will present four abstracts at the 47th Annual Meeting of Infectious Disease Society of America (IDSA) being held here October 29 through November 1, 2009. These abstracts advance the body of data surrounding respiratory syncytial virus (RSV) and influenza prevention, highlighting MedImmune's leadership in pediatric health.

Unnoticed by the nearby residents of St. Johnsbury, Vermont, tiny leaf beetles that flit among the maple and willow trees in the area have just provided some of the clearest evidence yet that environmental factors play a major role in the formation of new species.

At Vanderbilt University, graduate student Scott Egan and his adviser Daniel Funk, associate professor of biological sciences, obtained this new evidence from an experimental study published online this week in the early edition of the Proceedings of the National Academy of Sciences.

DETROIT – The race of kidney donors may affect the survival rates of transplant recipients according to a study by Henry Ford Hospital.

"We found that transplant between races had better outcomes than transplant across races," says Anita Patel, M.D., transplant nephrologist at Henry Ford Hospital Transplant Institute and lead author of the study.

"It is important to remember that the statistical difference in this observation is greatly outweighed by the life-giving benefits that recipients get from transplantation."

BUFFALO, NY (October 30, 2009) -- A husband and wife team of American paleontologists has discovered a new species of dinosaur that lived 112 million years ago during the early Cretaceous of central Montana.

Rockville, Md. (Oct. 30, 2009) — A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus. The results of this finding appear Oct.

WHAT: Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses.

The 'Red Alert for Women's Hearts' conference, taking place on 5 November 2009, at the European Heart House, Sophia Antipolis, France, will address the subject of Women and CVD. The conference is jointly organised by the European Society of Cardiology (ESC) and European Heart Network (EHN), as part of Work Package 6 of the EuroHeart project (1).

Heart disease and stroke are the leading causes of death for women worldwide, killing more than 8.6 million, more than the total number who die from cancer, tuberculosis, HIV/AIDS and malaria combined.

Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the November European Journal of Heart Failure.(1) The finding, say the authors, may even call into question the commonplace ethical requirement of most clinical trials that by choosing not to take part in the study a patient will not be disadvantaged.

A research team from the University of Castilla-La Mancha (UCLM) has analysed the presence of heavy metals in 12 species of mushroom collected from non-contaminated natural areas, and has found that the levels vary depending on the type of mushroom. The results of the study, which appears this month in the journal Biometals, show that the largest quantities of lead and neodymium are found in chanterelles.